Search for: "In Matter of Crouch"
Results 281 - 300
of 869
Sort by Relevance
|
Sort by Date
19 Aug 2019, 11:39 am
by Dennis Crouch Sanofi-Aventis U.S., LLC v. [read post]
15 Aug 2019, 11:16 am
by Dennis Crouch Nalpropion Pharmaceuticals, Inc. v. [read post]
5 Jul 2019, 7:57 am
by Dennis Crouch In re Global IP Holdings (Fed. [read post]
3 Jul 2019, 10:00 am
I have a friend of mine that is in the real estate business, and he and his partner prepare a lot of documents for execution on real estate matters. [read post]
3 Jul 2019, 8:05 am
by Dennis Crouch Athena Diagnostics, Inc. v. [read post]
2 Jul 2019, 5:38 am
To borrow a phrase from Mark Tushnet, his theory can be viewed as a type of defensive crouch constitutionalism. [read post]
30 Jun 2019, 10:24 pm
However, under the AD Act, it is not vilification if the act is a public act, done reasonably and in good faith, for religious instruction, or for other purposes in the public interest, including discussion or debate about any matter. [read post]
24 Jun 2019, 9:04 am
by Dennis Crouch Trademark rights have long held substantial sway and power in courts and among administrators who are often required by regulations to respect trademark rights. [read post]
10 Jun 2019, 9:56 pm
by Dennis Crouch The Federal Circuit released two non-precedential decisions today affirming lower court holdings of ineligibility. [read post]
23 May 2019, 9:31 am
by Dennis Crouch Glasswall Solutions Limited, et al. v. [read post]
9 May 2019, 10:49 am
by Dennis Crouch Swagway v Segway and ITC (Fed. [read post]
30 Apr 2019, 7:22 am
The French court found the SPC to be valid in light of the CJEU’s judgment in Gilead, as there is now no requirement that the combination should be the subject matter of the invention, and found that the CJEU’s judgment had no impact on Article 3(c). [read post]
28 Apr 2019, 8:20 am
On a rainy Friday morning in New York at the Fordham IP Conference, the first patents session on the patent track was on Biologics and Biosimilars, moderated by John Lee (Gilbert + Tobin, Sydney).Over to guest Kat, Amy Crouch (Simmons & Simmons), who reports on the session:"Cordula Schumacher (Arnold Ruess, Düsseldorf) kicked off the session by introducing the subject matter: “Biologics” are large, highly complex molecules produced by living cells… [read post]
28 Apr 2019, 7:45 am
Kat friend and Fordham guest Kat, Amy Crouch (Simmons & Simmons) reports on the session.Over to Amy: "Klaus Grabinski (Federal Court of Justice, Karlsruhe) started the discussion by outlining infringement of second medical use patents in German case law. [read post]
22 Apr 2019, 2:02 pm
(Boundy.2018.BadGuidance) Colleen Chien and Jiun-Ying Wu, Decoding Patentable Subject Matter, 2018 PatentlyO Patent Law Journal 1. [read post]
22 Apr 2019, 2:02 pm
(Boundy.2018.BadGuidance) Colleen Chien and Jiun-Ying Wu, Decoding Patentable Subject Matter, 2018 PatentlyO Patent Law Journal 1. [read post]
10 Apr 2019, 6:06 am
Marvel had moved to dismiss claiming that elements of Plaintiff’s works which had allegedly been copied were not protectable as a matter of law and were not, in any event, substantially similar to Defendants’ works. [read post]
8 Apr 2019, 8:03 pm
by Dennis Crouch Omega Patents LLC v. [read post]
3 Apr 2019, 12:48 pm
by Dennis Crouch A key point of argument and policy over the past decades has been the level of authority given to the USPTO as the government’s expert patent law agency. [read post]
28 Mar 2019, 9:07 am
by Dennis Crouch This case focuses on patents covering the opioid drug oxymorphone that Endo sells as Opana ER. [read post]
